These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26957267)

  • 1. Study on the relationship between miR-520g and the development of breast cancer.
    Ren GB; Wang L; Zhang FH; Meng XR; Mao ZP
    Eur Rev Med Pharmacol Sci; 2016; 20(4):657-63. PubMed ID: 26957267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of color Doppler ultrasound combined with plasma miR-21 and miR-27a in the diagnosis of breast cancer.
    Li M; Li Q; Yin Q; Wang Y; Shang JM; Wang LH
    Clin Transl Oncol; 2021 Apr; 23(4):709-717. PubMed ID: 33206330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating miR-195 as a Therapeutic Biomarker in Turkish Breast Cancer Patients.
    Cecene G; Ak S; Eskiler GG; Demirdogen E; Erturk E; Gokgoz S; Polatkan V; Egeli U; Tunca B; Tezcan G; Topal U; Tolunay S; Tasdelen I
    Asian Pac J Cancer Prev; 2016; 17(9):4241-4246. PubMed ID: 27797225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum miR-22 Could be a Potential Biomarker for the Prognosis of Breast Cancer.
    Shao Y; Yao Y; Xiao P; Yang X; Zhang D
    Clin Lab; 2019 Apr; 65(4):. PubMed ID: 30969075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The level of circulating miRNA-10b and miRNA-373 in detecting lymph node metastasis of breast cancer: potential biomarkers.
    Chen W; Cai F; Zhang B; Barekati Z; Zhong XY
    Tumour Biol; 2013 Feb; 34(1):455-62. PubMed ID: 23238818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of serum exosomal miR-148a as a novel prognostic biomarker for breast cancer.
    Li D; Wang J; Ma LJ; Yang HB; Jing JF; Jia MM; Zhang XJ; Guo F; Gao JN
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7303-7309. PubMed ID: 32706068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined detection of plasma miR-127-3p and HE4 improves the diagnostic efficacy of breast cancer.
    Lu M; Ju S; Shen X; Wang X; Jing R; Yang C; Chu H; Cong H
    Cancer Biomark; 2017; 18(2):143-148. PubMed ID: 27983524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of serum miR-21 in the pathogenesis of familial and triple negative breast cancer.
    Yang L; Feng Y; Qi P; Xu S; Zhou Y
    J Biol Regul Homeost Agents; 2016; 30(4):1041-1045. PubMed ID: 28078851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low levels of serum miR-99a is a predictor of poor prognosis in breast cancer.
    Li J; Song ZJ; Wang YY; Yin Y; Liu Y; Nan X
    Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNAs in plasma as early detection markers for breast cancer.
    Cuk K; Zucknick M; Heil J; Madhavan D; Schott S; Turchinovich A; Arlt D; Rath M; Sohn C; Benner A; Junkermann H; Schneeweiss A; Burwinkel B
    Int J Cancer; 2013 Apr; 132(7):1602-12. PubMed ID: 22927033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs and metastasis-related gene expression in Egyptian breast cancer patients.
    Hafez MM; Hassan ZK; Zekri AR; Gaber AA; Al Rejaie SS; Sayed-Ahmed MM; Al Shabanah O
    Asian Pac J Cancer Prev; 2012; 13(2):591-8. PubMed ID: 22524830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Clinical Evaluation of Circulating MiR-106a and Raf-1 as Breast Cancer Diagnostic and Prognostic Markers.
    Ahmed Mohmmed E; Shousha WG; El-Saiid AS; Ramadan SS
    Asian Pac J Cancer Prev; 2021 Nov; 22(11):3513-3520. PubMed ID: 34837907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis.
    Yan LX; Huang XF; Shao Q; Huang MY; Deng L; Wu QL; Zeng YX; Shao JY
    RNA; 2008 Nov; 14(11):2348-60. PubMed ID: 18812439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased expression of MicroRNA-200 family in human breast cancer is associated with lymph node metastasis.
    Xu F; He H; Huang W; Lin Y; Luo S; Du Q; Duan R
    Clin Transl Oncol; 2016 Mar; 18(3):283-8. PubMed ID: 26201425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulated microRNA-124 expression as predictive biomarker and its prognostic significance with clinicopathological features in breast cancer patients.
    Arabkheradmand A; Safari A; Seifoleslami M; Yahaghi E; Gity M
    Diagn Pathol; 2015 Sep; 10():178. PubMed ID: 26415857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum microRNA-195 is down-regulated in breast cancer: a potential marker for the diagnosis of breast cancer.
    Zhao FL; Dou YC; Wang XF; Han DC; Lv ZG; Ge SL; Zhang YK
    Mol Biol Rep; 2014 Sep; 41(9):5913-22. PubMed ID: 25103018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma microRNAs Predict Chemoresistance in Patients With Metastatic Breast Cancer.
    Shao B; Wang X; Zhang L; Li D; Liu X; Song G; Cao H; Zhu J; Li H
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819828709. PubMed ID: 30786836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower expression of miR-218 in human breast cancer is associated with lymph node metastases, higher grades, and poorer prognosis.
    Ahmadinejad F; Mowla SJ; Honardoost MA; Arjenaki MG; Moazeni-Bistgani M; Kheiri S; Teimori H
    Tumour Biol; 2017 Aug; 39(8):1010428317698362. PubMed ID: 28857013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
    Wang B; Li J; Sun M; Sun L; Zhang X
    IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of microRNAs-21/221 as potential breast cancer biomarkers in Egyptian women.
    Motawi TM; Sadik NA; Shaker OG; El Masry MR; Mohareb F
    Gene; 2016 Sep; 590(2):210-9. PubMed ID: 26827795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.